Suchergebnisse - "Ahmadi, Majid"

PubPharm (8)

1

Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients

enthalten in: Journal of cellular physiology | 2021

von Tahmasebi, S. | El-Esawi, M. | Mahmoud, Z. | +9

2

Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2

enthalten in: Life sciences | 2021

von Tahmasebi, S. | Saeed, B. | Temirgalieva, E. | +11

3

Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients

enthalten in: International immunopharmacology | 2020

von Valizadeh, H. | Abdolmohammadi-Vahid, S. | Danshina, S. | +9

4

The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients : A randomized, double-blind, placebo-controlled clinical trial

enthalten in: Journal of cellular biochemistry | 2020

von Ahmadi, M. | Hajialilo, M. | Dolati, S. | +10

5

Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis

enthalten in: Journal of neuroimmunology | 2019

von Dolati, S. | Babaloo, Z. | Ayromlou, H. | +8

6

Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators

enthalten in: Pharmacological reports : PR | 2018

von Dolati, S. | Ahmadi, M. | Aghebti-Maleki, L. | +5

7

Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis

enthalten in: International immunopharmacology | 2018

von Dolati, S. | Ahmadi, M. | Rikhtegar, R. | +5

8

Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial

enthalten in: Journal of cellular physiology | 2018

von Dolati, S. | Aghebati-Maleki, L. | Ahmadi, M. | +9

1
[1]